Pharmafile Logo

Webinar – Immuno-oncology’s Evolution: Implications for Pharma Market Researchers

November 23, 2016 | immuno-oncology, webinar 

In association with PMGroup

Immuno-oncology therapies that harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. Until recently only a few products had reached the market for a limited number of indications.

In this webinar, oncology market research experts Sue Marett, Phil Rosenberg and Claire Fradet Aubignat will explore the key features of the immuno-oncology market and outline the critical success factors that manufacturers need to consider in order to remain competitive.

Find out more: http://www.researchpartnership.com/news/2016/11/webinar-immuno-oncologys-evolution/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Webcast:

UX beyond the website: Insights for the age of omnichannel

News:

MedTech Qualitative Specialist joins Research Partnership

Guide

How to embrace behavioural science principles in healthcare MR

Article

A glimmer of hope for Alzheimer’s patients, but at what cost?

Video

Virtual Conference Live

Report

Digital Health Tools - Physician Trends

Webcast

Oncology landscape: How innovative market research methods can navigate you to success

Article:

The disparity of patient experiences with Crohn’s Disease in Europe and Japan

Research Partnership’s MedTech Division appoints two Directors

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Webcast: Influencing HCP behaviours – Is now the perfect opportunity?

Putting behavioural science at the forefront of market research